Live feed18:00:00·10dPRReleasevia QuantisnowKIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanomaByQuantisnow·Wall Street's wire, on your screen.IMCR· Immunocore Holdings plcHealth Care
